WYETH 4
4 · WYETH · Filed Oct 19, 2009
Insider Transaction Report
Form 4
WYETHWYE
Portwood Charles A
Exec. VP TO&PS
Transactions
- Disposition to Issuer
Employee Stock Option
2009-10-15−37,150→ 0 totalExercise: $56.00→ Common Stock (37,150 underlying) - Disposition to Issuer
Phantom Stock Units
2009-10-15−443.55→ 0 total(indirect: SESP)→ Common Stock (443.55 underlying) - Disposition to Issuer
Common Stock
2009-10-15−41,018.251→ 0 total - Disposition to Issuer
Common Stock (401(k))
2009-10-15−1,111.45→ 0 total(indirect: By 401 (k) Plan) - Disposition to Issuer
Employee Stock Option
2009-10-15−60,000→ 0 totalExercise: $60.70→ Common Stock (60,000 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$8.53/sh−35,000$298,550→ 0 totalExercise: $41.05→ Common Stock (35,000 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$9.36/sh−63,000$589,680→ 0 totalExercise: $40.22→ Common Stock (63,000 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15−60,000→ 0 totalExercise: $56.98→ Common Stock (60,000 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$6.01/sh−46,500$279,465→ 0 totalExercise: $43.57→ Common Stock (46,500 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$1.36/sh−43,710$59,446→ 0 totalExercise: $48.22→ Common Stock (43,710 underlying) - Disposition to Issuer
Employee Stock Option
2009-10-15$5.02/sh−37,150$186,493→ 0 totalExercise: $44.56→ Common Stock (37,150 underlying)
Footnotes (6)
- [F1]Pursuant to the Agreement and Plan of Merger by and among Wyeth, Pfizer Inc. and Wagner Acquisition Corp. dated as of January 25, 2009 (as amended, the "Merger Agreement"), each of these shares was cancelled at the effective time of the merger and converted into the right to receive $33.00 in cash and 0.985 of a share of Pfizer Inc. common stock, less any applicable tax withholding.
- [F2]Represents an estimate of the common stock equivalents underlying the reporting person's holdings of units in the Wyeth common stock fund in the Wyeth 401(k) plan as of a recent date.
- [F3]Each share in the Wyeth common stock fund in the Wyeth 401(k) was cancelled at the effective time of the merger and converted into the right to receive $33.00 in cash and 0.985 of a share of Pfizer Inc. common stock.
- [F4]Pursuant to the Merger Agreement, each outstanding and unexercised option, whether vested or unvested, was cancelled at the effective time of the merger in exchange for cash equal to the product of (a) the number of shares underlying such option and (b) the excess, if any, of the per share value of the merger consideration of $49.58 over the per share exercise price of the option, less any applicable tax withholding.
- [F5]Pursuant to the Merger Agreement, each phantom stock unit in the Supplemental Employee Savings Plan ("SESP") was converted at the effective time of the merger into the the right to receive an amount equal to notional $33.00 in cash plus 0.985 of a phantom share of Pfizer Inc. common stock in accordance with the SESP.
- [F6]Represents phantom stock units in the SESP.